In our pilot experiment, we performed comparative analysis of CD117, EpCam and CD81 abundance on EVs isolated from ascitic fluids of the patient with primary tumor (ovarian papillary cystadenocarcinoma) and of the same patient with post-treatment tumor relapse. Here, CD81 is linked to neoplasm.